McKinley Medical UK is formed in July 2001, with three employees in total.
In November, Stephen Thorpe has initial discussions with CME regarding marketing CME pumps in the UK.
CME Medical UK and CME develop epidural and PCA variants of the BodyGuard™ pump for the UK.
The first BodyGuard™ pain pump sales are made to Antrim area hospitals in Northern Ireland.
First placements of the BodyGuard™ pain pumps in the UK.
The T34™ ambulatory syringe pump is launched.
CME acquires McKinley Medical UK from its US owners to form CME McKinley UK.
T60™ and TPCA™ are launched. UK business team expands rapidly.
Continued investment sees the team double in size once again.
The BodyGuard 595™ regional analgesia pump is launched.
Three years into the new partnership with CME, the company rebrands as CME Medical.
The T34™ Ambulatory Syringe Pump becomes the market leader in pain management in palliative care (50% of Graseby MS drivers in the UK are replaced).
NPSA alert drives revenues to £14.7m, a record year.
CME Medical employs some 75 people across the UK with some ten agency and sub-distributor staff. Clinical training receives the Skills for Health Quality Mark.
Chairman Stephen Thorpe is North winner in EY’s Entrepreneur of the Year awards. Technical training receives the Skills for Health Quality Mark.
CME Medical partners with ‘The Impact Foundation’ to raise money to help with relief efforts following the earthquakes in Nepal.
CME Medical celebrates 15 years of delivering innovation to support the needs of patients and healthcare professionals.
BD (Becton Dickinson) acquires CME Medical UK Ltd.